, related to Figure 2D . A representative dose-response study of compound 2 against AceMIF-induced chemotaxis. The chemoattractant activities of AceMIF in the presence of compound 2 were measured using human peripheral blood monocytes (PBMCs) isolated from whole blood by centrifugation. These assays were carried out in 24-well tissue culture plates utilizing 8.0 m cell culture inserts. The cells were placed in the cell culture insert
, related to Figure 2D . A representative dose-response study of compound 2 against AceMIF-induced chemotaxis. The chemoattractant activities of AceMIF in the presence of compound 2 were measured using human peripheral blood monocytes (PBMCs) isolated from whole blood by centrifugation. These assays were carried out in 24-well tissue culture plates utilizing 8.0 m cell culture inserts. The cells were placed in the cell culture insert with various concentration of compound 2, followed by incubation for 3 h at 37 °C, 5% CO 2 . Cells that migrated through the membrane were fixed in methanol and stained with Geimsa, followed by counting under light microscopy. Results are expressed as the mean number of cells counted per high power field for each of two replicates. terminal residues of an adjacent trimer. In the original crystallization conditions for apo-AceMIF, the carboxyl terminal methionine from one trimer makes tight interactions with the active site residues of another trimer (PDB ID 2OS5) that is due to crystal packing artifacts [1] . This hydrogen bond is within the optimum hydrogen bond distance reported for methionine residues [3] . carbonic anhydrase and can be modified to lose diuretic property for anti-AceMIF specific inhibition. Independent of the Na-K-Cl cotransporter target and mechanism, compound 2 is also a sulfonamide inhibitor of carbonic anhydrase [4] . The interconversion of carbon dioxide and bicarbonate by carbonic anhydrase maintains the acidity of blood and tissues. When the carbonic anhydrase is inhibited, the acid-base balance in the blood is disrupted and results in acidosis, another mechanism leading to diuresis. Carbonic anhydrase has been co-crystallized with compound 2 (furosemide) (PDB ID 1Z9Y) and reveals that the sulfonamide is completely buried within the protein, making both covalent (with zinc ion) and non-covalent (with the active site residues) interactions [5] . Since there is no space next to the chloride atom and the sulfonamide, chemical modification of these two groups could remove binding to carbonic anhydrase and provide specificity for AceMIF. The reliability of the assay was evaluated by calculating a Z-factor (Z') (Eq S1), which is statistical parameter to assess whether the response of an assay is robust for high throughput screening.
Z'=1 -(3sigma(+) + 3sigma(-))/Absolute[mu(+) -mu(-)] (S1)

Measurement of K i
HPP was dissolved in 0.5 M acetate buffer, pH 6.0 to the concentration of 50 mM and incubated overnight and allowed to equilibrate into the enol to keto forms at room temperature. Fifty nM MIF was premixed in 424 mM boric acid and transferred to a 96 well UV transparent bottom half-area plate (Corning, NY).
Inhibitors were dissolved in DMSO to 50 mM and added into each well and incubated for more than 10 minutes until the assay was started by addition of HPP at various concentrations. MIF activity was monitored at 306 nm for formation of the borate-enol complex using the plate reader Infinite M200
(TECAN, Durham, NC) for 90 seconds. Calculation of initial velocities and nonlinear regression were repeated three times and combined for analysis using the program Prism4 (GRAPHPAD, La Jolla, CA).
Toxicity against A. ceylanicum ex vivo
Worm viability was monitored by light microscopy at 24h time points, and the data are represented as the percentage of surviving worms relative to controls (mean of duplicate wells). Data are presented as a Kaplan-Meier survival plot.
Statistical analyses were performed using the logrank test to compare survival curves of AceMIF inhibitor-treated and control worms. P values of <0.05 were considered significant.
X-ray Crystallography
Single crystals were flash frozen in the mother liquor with 20% glycerol for data collection. Diffraction data were collected at X29 beam line of National Synchrotron Light Source (NSLS) in the Brookhaven National Laboratory (BNL), Upton, NY or at the Yale University School of Medicine (see Table S1 for details of data collection and structural refinement). The data were reduced using MOSFLM and scaled with SCALA in the CCP4 program package [6] . Molecular replacement was performed using PHASER and rigid body refinement was done by Refmac5 [7] . Crystallographic molecular dynamics and thermal factor refinement were done with CNS [8] , and routine structure refinement was done by Refmac5 with manual intervention of protein and the inhibitor model using COOT [9] . The inhibitor model and its hetero atom library were generated by the PRODRG2 server to produce the PDB format [10] . The electron density of compound 2 and the refined protein structure were visualized using PyMol [11] .
Hydrogen bonds were searched by HBPlus integrated in SPOCK [12] .
Hydrophobic interactions were analyzed by LigPlot [13] . The protein surface was generated by Chimera [14] and the electrostatic potential was calculated by APBS [15] integrated in PyMolX11Hybrid(1.0). The two inhibited protein structures were superposed using the program THESEUS [16] to quantitate conformational changes upon different inhibitor binding and also to visualize positional difference of the bound inhibitors.
Meta-analysis of the GenPlus library
To characterize the GenPlus library (MicroSource Discovery Systems, Inc., 
